Skip to main content
. 2018 Dec;8(6):814–819. doi: 10.21037/cdt.2018.09.12

Table 2. Comparison of frequency and mean age of hospitalizations in adult congenital heart disease patients with vs. without comorbidities (n=255,355).

Comorbidities Patients with comorbidities Patients without comorbidities
Number (%) Age in years at hospitalization (mean ± SD) Number (%) Age in years at hospitalization (mean ± SD)
Hematology
   Deficiency anemias 42,950 (16.8) 60±19 212,405 (83.2) 56±19
   Chronic blood loss anemia 4,170 (1.6) 48±22 251,185 (98.4) 57±19
   Coagulopathy 28,660 (11.2) 59±18 226,695 (88.8) 57±19
Rheumatology
   Rheumatoid arthritis/collagen vascular diseases 8,005 (3.1) 62±17 247,350 (96.9) 57±19
Pulmonology
   Chronic pulmonary disease 51,985 (20.4) 61±17 203,370 (79.6) 56±19
   Pulmonary circulation disorders 16,585 (6.5) 60±19 238,770 (93.5) 57±19
   Pneumonia 20,050 (7.9) 60±19 235,305 (92.1) 57±19
   Pulmonary hypertension 32,410 (12.7) 61±18 222,945 (87.3) 56±19
Psychiatry
   Alcohol abuse 10,220 (4.0) 54±14 245,135 (96.0) 57±19
   Drug abuse 10,140 (4.0) 42±14 245,215 (96.0) 58±19
   Depression 29,205 (11.4) 57±17 226,150 (88.6) 57±19
   Anxiety 30,960 (12.1) 54±18 224,395 (87.9) 57±19
   Psychoses 11,425 (4.5) 53±17 243,930 (95.5) 57±19
Endocrine/metabolic
   Diabetes, uncomplicated 45,345 (17.8) 64±14 210,010 (82.2) 55±19
   Diabetes with chronic complications 11,470 (4.5) 64±14 243,885 (95.5) 57±19
   Hypothyroidism 32,275 (12.6) 64±17 223,080 (87.4) 56±19
   Obesity 37,835 (14.8) 56±15 217,520 (85.2) 57±19
   Dyslipidemia 101,150 (39.6) 65±14 154,205 (60.4) 52±20
   Fluid and electrolyte disorders 71,230 (27.9) 60±18 184,125 (72.1) 56±19
Vascular
   Hypertension 140,210 (54.9) 64±15 115,145 (45.1) 49±19
   Peripheral vascular disorders 28,255 (11.1) 64±15 227,100 (88.9) 56±19
   Arterial thromboembolism 2,160 (0.8) 57±17 253,195 (99.2) 57±19
   Venous thromboembolism 23,025 (9.0) 58±18 232,330 (91.0) 57±19
Oncology
   Solid tumor without metastasis 3,385 (1.3) 68±14 251,970 (98.7) 57±19
   Metastatic cancer 3,070 (1.2) 64±14 252,285 (98.8) 57±19
   Weight loss 12,620 (4.9) 61±19 242,735 (95.1) 57±19
Neurology
   Acute cerebrovascular disorder 33,145 (13.0) 62±16 222,210 (87.0) 56±19
   Other neurological disorders 18,520 (7.3) 59±19 236,835 (92.7) 57±19
   Paralysis 11,535 (4.5) 58±18 243,820 (95.5) 57±19
Renal
   Renal failure 33,550 (13.1) 67±16 221,805 (86.9) 55±19
Gastroenterology/hepatology
   Liver disease 9,800 (3.8) 54±16 245,555 (96.2) 57±19
   Biliary tract disorder 4,915 (1.9) 56±20 250,440 (98.1) 57±19
   Pancreas disorders 2,665 (1.0) 53±19 252,690 (99.0) 57±19
   Intestinal malabsorption 1,320 (0.5) 46±21 254,035 (99.5) 57±19
   Peptic ulcer disease excluding bleeding 45 (0.02) 61±24 255,310 (99.9) 57±19
   Congestive hepatopathy 610 (0.2) 59±18 254,745 (99.8) 57±19
   Protein losing enteropathy 400 (0.2) 28±11 254,955 (99.8) 57±19